Related Experiment Video
Updated: Jun 1, 2025

06:10
Following Cell-fate in E. coli After Infection by Phage Lambda
Published on: October 14, 2011
23.3K
'PHACE' on the 'face'
Ie Lien Romero1, Chia Saw2,3, Noel David Friesen2,3
1School of Medicine, The University of Notre Dame Australia, Fremantle, Western Australia, Australia ielien.romero@outlook.com.
BMJ Case Reports
|January 19, 2025
Summary
Large facial infantile haemangiomas in infants may signal PHACE syndrome, a rare neurocutaneous disorder. Early diagnosis and multidisciplinary management are crucial for affected children.
Area of Science:
- Pediatrics
- Dermatology
- Genetics
Background:
- Infantile haemangiomas are common benign vascular tumors in infants.
- Large facial haemangiomas (≥5 cm) can be associated with serious underlying conditions.
- PHACE syndrome is a neurocutaneous disorder characterized by specific malformations and defects.
Purpose of the Study:
- To report an unusual case of possible PHACE syndrome in a young male toddler.
- To discuss the clinical assessment and diagnostic approach for PHACE syndrome.
- To highlight the importance of a multidisciplinary approach for managing large facial haemangiomas.
Main Methods:
- Case report of a young male toddler with a large facial haemangioma.
- Review of clinical presentation and diagnostic workup for PHACE syndrome.
- Discussion of standardized guidelines for managing large facial haemangiomas.
Main Results:
- The case presented an unusual manifestation of potential PHACE syndrome.
- Diagnosis and management of PHACE syndrome require careful clinical evaluation.
- A multidisciplinary team is essential for comprehensive patient care.
Conclusions:
- Large facial haemangiomas warrant thorough investigation for PHACE syndrome.
- Awareness of PHACE syndrome's clinical spectrum is critical for timely diagnosis.
- Standardized guidelines and a collaborative approach improve outcomes for PHACE syndrome patients.
Related Concept Videos
Lytic Cycle of Bacteriophages
70.2K
Bacteriophages, also known as phages, are specialized viruses that infect bacteria. A key characteristic of phages is their distinctive “head-tail” morphology. A phage begins the infection process (i.e., lytic cycle) by attaching to the outside of a bacterial cell. Attachment is accomplished via proteins in the phage tail that bind to specific receptor proteins on the outer surface of the bacterium. The tail injects the phage’s DNA genome into the bacterial cytoplasm. In the...
70.2K
Lysogenic Cycle of Bacteriophages
61.8K
In contrast to the lytic cycle, phages infecting bacteria via the lysogenic cycle do not immediately kill their host cell. Instead, they combine their genome with the host genome, allowing the bacteria to replicate the phage DNA along with the bacterial genome. The incorporated copy of the phage genome is called the prophage. Some prophages can re-activate and enter the lytic cycle. This often occurs in response to a perturbation, such as DNA damage, but can also transpire in the absence of...
61.8K
Immune Surveillance by NK Cells and Phagocytes
1.3K
Immune surveillance is an integral part of the innate immune system, involving the continuous monitoring of peripheral tissues to detect and respond to pathogens, infected cells, or cancerous cells. This surveillance is conducted primarily by natural killer (NK) cells and phagocytes, which employ distinct but complementary mechanisms to identify and eliminate threats.
Natural Killer Cells: The Fast Responders
NK cells are large granular lymphocytes found in the blood and lymphatic system. These...
Natural Killer Cells: The Fast Responders
NK cells are large granular lymphocytes found in the blood and lymphatic system. These...
1.3K
Phagocytosis
6.0K
Cells pull particles inward and engulf them in spherical vesicles in an energy-requiring process called endocytosis. Phagocytosis ("cellular eating") is one of three major types of endocytosis. Cells use phagocytosis to take in large objects, such as other cells (or their debris), bacteria, and even viruses.
The objective of phagocytosis is often destruction. Cells use phagocytosis to eliminate unwelcome visitors, like pathogens (e.g., viruses and bacteria). Many immune system cells,...
The objective of phagocytosis is often destruction. Cells use phagocytosis to eliminate unwelcome visitors, like pathogens (e.g., viruses and bacteria). Many immune system cells,...
6.0K
Phagocytosis of Apoptotic Cells
3.6K
Cells undergoing apoptosis form apoptotic bodies that must be removed immediately to prevent inflammation, autoimmune diseases, and necrosis. Phagocytosis is carried out by professional phagocytes such as macrophages or immature dendritic cells. Non-professional phagocytes such as epithelial cells and fibroblasts also take part in this process; however, they are not as effective as professional phagocytes.
Normal cells contain receptors that prevent them from being recognized...
Normal cells contain receptors that prevent them from being recognized...
3.6K
CRISPR and crRNAs
16.6K
Bacteria and archaea are susceptible to viral infections just like eukaryotes; therefore, they have developed a unique adaptive immune system to protect themselves. Clustered regularly interspaced short palindromic repeats and CRISPR-associated proteins (CRISPR-Cas) are present in more than 45% of known bacteria and 90% of known archaea.
The CRISPR-Cas system stores a copy of foreign DNA in the host genome and uses it to identify the foreign DNA upon reinfection. CRISPR-Cas has three different...
The CRISPR-Cas system stores a copy of foreign DNA in the host genome and uses it to identify the foreign DNA upon reinfection. CRISPR-Cas has three different...
16.6K

